How clinical trials work and the critical role that they play in drug development

Mathumai Govindarajan Abbreviations Adverse Drug Reaction (ADR); Clinical Trials Authorization (CTA); FDA Adverse Event Reporting System (FAERS); Food and Drug Administration (FDA); Medicines and Healthcare Products Regulatory Agency (MHRA); New Drug Application (NDA); Non-small Cell Lung Cancer (NSCLC); Overall Survival (OS); Population, Intervention, Comparator, Outcomes (PICO); Progression-free Survival (PFS); Randomized Clinical Trials (RCT); Therapeutics Goods […]

Advanced Therapies Europe 2022

    On the 31st August and 1st September, 2022, PMM volunteer and team member, Rithika Ganesh, attended the annual Advanced Therapies Europe Conference which was held at the Royal Lancaster hotel in London, United Kingdom. The Advanced Therapies Europe 2022 conference focused on exploring the commercialization of advanced therapy medicinal products (ATMPs), with talks […]

What is Digital Health and how is it revolutionizing healthcare?

Olivia Crossley   Keywords Arrhythmia, Artificial intelligence, Blood Pressure, Consultant, Digital health, Electrodes, EEG, ECG, FDA, Machine Learning, Side effects, Telemedicine, Ultrasound, UK’s General Data Protection Regulation, Wearable technologies Digital technologies are electronic devices that analyze and store different kinds of information. These technologies have revolutionized how we communicate, learn, and shop. Now, digital devices […]

Advanced Therapies Congress, 24-25 May, 2022, ExCel, London

On the 24th of May, 2022, PMM team members, Xuanqi Song and Sam Jarada, attended the Advanced Therapies Congress held at the London ExCeL. The Advanced Therapies Congress explored, defined, and attempted to tackle the main challenges currently being faced when it comes to the development of patient access to advanced therapy medicinal products (ATMP). […]